Munafa Stock Market Course + Intraday & FNO calls 
EDIT NEWS why is Editas Medicine, Inc. price falling or rising
EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising
EDIT Editas Medicine is falling or rising technical reasons
Technical analysis forecast of Editas Medicine Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Editas Medicine EDIT at this time. Stock is rising and might rise more.
It appears as if Editas Medicine EDIT gave a large move recently.
Stock of Editas Medicine (EDIT) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.
EDIT Editas Medicine is falling or rising NEWS fundamental reasons
Credit provided by capital markets will overtake bank credit: Kotak Mahindra AMC chief Nilesh Shah Mutual fund credit is set to surpass bank credit. Nilesh Shah of Kotak Mahindra AMC predicts this shift. He urges Indians to invest wisely, moving away from unproductive habits. Radhika Gupta of Edelweiss Mutual Fund suggests incentives for early investmen - NEWS as on 2025-12-09 indiatimes.com
Banks and NBFCs remain healthy, credit to commercial sector rises, says RBI Governor The Reserve Bank of India reported robust financial parameters for banks and non-banking finance companies, facilitating increased resource flow to the commercial sector. Capital adequacy and asset quality remain strong, with credit growth bolstered by gre - NEWS as on 2025-12-05 indiatimes.com
RBI orders weekly loan data reporting to credit information cos from April 1, 2026 RBI has mandated that lenders submit borrower data to credit bureaus weekly instead of fortnightly from April 1, 2026. The move aims to improve credit underwriting and loan monitoring. Lenders must update data on fixed dates each month, share full monthly - NEWS as on 2025-12-04 indiatimes.com
Credit Acceptance Reaches Analyst Target Price In recent trading, shares of Credit Acceptance Corp (Symbol: CACC) have crossed above the average analyst 12-month target price of 4.40, changing hands for 6.24/share. When a stock reaches the target an analyst has set, the analyst logically has tw - NEWS as on 2025-12-03 nasdaq.com
MFI body seeks greater penetration of credit flow for growth Microfinance institutions in West Bengal need more credit to reach the bottom of the pyramid. Currently, only one-third of the target segment accesses formal credit. This gap hinders economic activity and sector growth. India's MFI sector has Rs 3.4 lakh c - NEWS as on 2025-12-02 indiatimes.com
More announcements and NEWS
EDIT Editas Medicine, Inc. current price & indicator signals
Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 10 Wed Dec 2025 | 2.60 | 2.36 to 2.67 | 6.56% | 1.82 times |
| 09 Tue Dec 2025 | 2.44 | 2.36 to 2.49 | 0.83% | 0.88 times |
| 08 Mon Dec 2025 | 2.42 | 2.37 to 2.51 | 0% | 0.8 times |
| 05 Fri Dec 2025 | 2.42 | 2.38 to 2.50 | -0.82% | 1 times |
| 04 Thu Dec 2025 | 2.44 | 2.29 to 2.49 | 2.95% | 1.01 times |
| 03 Wed Dec 2025 | 2.37 | 2.12 to 2.37 | 12.32% | 1.44 times |
| 02 Tue Dec 2025 | 2.11 | 2.09 to 2.31 | -3.65% | 1.2 times |
| 01 Mon Dec 2025 | 2.19 | 2.16 to 2.38 | -9.13% | 1.24 times |
| 28 Fri Nov 2025 | 2.41 | 2.34 to 2.41 | 0.42% | 0.75 times |
| 26 Wed Nov 2025 | 2.40 | 2.33 to 2.41 | 0.42% | 0.78 times |
| 25 Tue Nov 2025 | 2.39 | 2.35 to 2.52 | -4.02% | 0.91 times |
| 24 Mon Nov 2025 | 2.49 | 2.42 to 2.55 | 2.89% | 0.77 times |
Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
